No Data
No Data
EXCLUSIVE: February's 20 Most-Searched Tickers On Benzinga Pro – Where Do Tesla, Palantir, Alibaba, Nvidia Rank?
Piper Sandler Maintains Neutral on Tempus AI, Lowers Price Target to $55
Natera Receives New Patent Related To Testing Of Single Nucleotide Variants In Circulating-Tumor DNA
Cathie Wood's Monday Moves: Ark Buys Tempus AI Dip And Airbnb Spike— Goes Shopping For Coinbase Stock Amid Trump Tariff Crypto Meltdown
Recursion Pharmaceuticals' Update Could Shed Light On Pipeline, Cost-Saving Plans, Analyst Says
B of A Securities Maintains Neutral on Tempus AI, Raises Price Target to $60